Biomolecules & Biomedicine (Nov 2003)

Olanzapine in Treatment of Patients With Bipolar 1 Disorder And Panic Comorbidity: A Case Study

  • Lilijana Oruč,
  • Semra Čavaljuga

DOI
https://doi.org/10.17305/bjbms.2003.3496
Journal volume & issue
Vol. 3, no. 4

Abstract

Read online

Anxiety disorders are frequently co-morbid with bipolar disorders (BP). Anxiety symptoms can have a great impact on course of illness and patient’s quality of life. Olanzapine is the first antipsychotic approved as a mood stabilizing agent. In this paper two cases of BP 1 disorder where panic attacks co-occur treated with olanzapine were presented. In both cases olanzapine showed very good effects in treatment of panic symptoms within the course of BP disorder.

Keywords